๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Genetically determined differences in drug metabolism as a risk factor in drug toxicity

โœ Scribed by Eichelbaum, M.; Kroemer, H.K.; Mikus, G.

Book ID
122015080
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
638 KB
Volume
64-65
Category
Article
ISSN
0378-4274

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Identification of genetic differences in
Identification of genetic differences in drug metabolism: Prediction of individual risk of toxicity or cancer
โœ Daniel W. Nebert ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 448 KB

differences exist in the regulation of at least some of the P450s (10). As the molecular mechanisms that underlie induction of human liver P45Os are characterized, it is likely that cell-free assays will be developed to screen drugs for induction properties. These two reports describe recombinant D

Thalidomide-induced neuropathy and genet
Thalidomide-induced neuropathy and genetic differences in drug metabolism
โœ C. C. Harland; G. B. Steventon; J. R. Marsden ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 639 KB

A pharmacogenetic predisposition to thalidomide-induced neuropathy has been investigated. Differences of drug metabolism were examined in 16 patients with severe orogenital ulceration, who were treated with thalidomide (< 200 mg/day) for 0.3-5.0 years. Eight had evidence of early peripheral neuropat